Association of ATM Alterations with Outcomes After 177Lu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer.

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42785951

Ali T Arafa; Ella Boytim; Emmanuel S Antonarakis; Ian J Okazaki; Justin Hwang; Lauren Yu; Lily Kollitz; Nicholas A Zorko; Scott M Dehm; Vikrant Mahajan; Zuzan Cayci

Sep 25, 2026